BioMarin Pharmaceutical Inc. Investor Relations Manager Salaries in Boulder | Comparably
Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of the genetic conditions that it seeks to treat, helping to better the lives of those struggling with rare genetic disease. BioMarin discoveries have led to eight first or best-in-class commercial treatments and a pipeline of multiple product candidates applying the same science-driven, patient-forward approach to broader group of genetic disorders. The more innovative solutions developed, the more lives BioMarin can impact. read more
EMPLOYEE
PARTICIPANTS
50
TOTAL
RATINGS
467
HR or Marketing? Claim Your Free Employer Account

BioMarin Pharmaceutical Inc. Investor Relations Manager Salaries in Boulder

The average BioMarin Pharmaceutical Inc. Investor Relations Manager in Boulder earns an estimated $89,915 annually. BioMarin Pharmaceutical Inc. Investor Relations Manager compensation is $2,612 more than the US average for a Investor Relations Manager.

Last updated 10 months ago.

$51k
$64k
$75k
$85k
$114k
$175k
$89,915
Average Compensation
$89,915
avg. base

Investor Relations Manager Salaries at BioMarin Pharmaceutical Inc.

* estimated salary

Compensation at BioMarin Pharmaceutical Inc. by Department

Investor Relations Manager Compensation by Gender (All Companies)

The average female Investor Relations Manager at companies similar size to BioMarin Pharmaceutical Inc. reported making $113,250, while the average male Investor Relations Manager at similar sized companies reported making $68,100.

Investor Relations Manager Compensation by Ethnicity (All Companies)

The average Caucasian Investor Relations Manager at companies similar size to BioMarin Pharmaceutical Inc. reported making $102,750, while the average African American/Black Investor Relations Manager at similar sized companies reported making $76,200.

How Investor Relations Managers at BioMarin Pharmaceutical Inc. Rate Their Compensation

The majority of Investor Relations Managers at BioMarin Pharmaceutical Inc. believe they're compensated fairly. 100% of Investor Relations Managers at BioMarin Pharmaceutical Inc. say they receive annual bonuses, and the vast majority (77%) are satisfied with their benefits. See more compensation ratings at BioMarin Pharmaceutical Inc.

×
Rate your company